5 Fastest Growing Health Tech Companies in the World

2. Immunocore Holdings plc (NASDAQ:IMCR)

YoY Growth: 43.05% 

Immunocore Holdings plc (NASDAQ:IMCR) had a revenue of $249.4 million in 2023. Immunocore Holdings plc (NASDAQ:IMCR)’s lead product candidate tebentafusp is a first-in-class bispecific T-cell engager and has shown promising results in the treatment of metastatic uveal melanoma which is a rare and aggressive form of eye cancer. Tebentafusp demonstrated a significant improvement in overall survival compared to the standard of care, with a 31% reduction in the risk of death, in a clinical trial.